These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 7500467)
21. Alpha 1 adrenoceptor subtypes in the human prostate. Lepor H; Tang R; Meretyk S; Shapiro E J Urol; 1993 Mar; 149(3):640-2. PubMed ID: 8094762 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of zinc and copper interaction with the human alpha(1A)-adrenoceptor. Ciolek J; Maïga A; Marcon E; Servent D; Gilles N Eur J Pharmacol; 2011 Mar; 655(1-3):1-8. PubMed ID: 21262225 [TBL] [Abstract][Full Text] [Related]
23. Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues. O'Malley SS; Chen TB; Francis BE; Gibson RE; Burns HD; DiSalvo J; Bayne ML; Wetzel JM; Nagarathnam D; Marzabadi M; Gluchowski C; Chang RS Eur J Pharmacol; 1998 May; 348(2-3):287-95. PubMed ID: 9652345 [TBL] [Abstract][Full Text] [Related]
24. Characterization, localization and distribution of alpha1 adrenoceptor subtype in male rabbit urethra. Nishi K; Latifpour J; Saito M; Foster HE; Yoshida M; Weiss RM J Urol; 1998 Jul; 160(1):196-205. PubMed ID: 9628650 [TBL] [Abstract][Full Text] [Related]
25. Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section. Kobayashi S; Tang R; Shapiro E; Lepor H J Urol; 1993 Dec; 150(6):2002-6. PubMed ID: 8230553 [TBL] [Abstract][Full Text] [Related]
26. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Lepor H; Tang R; Shapiro E Prostate; 1993; 22(4):301-7. PubMed ID: 8098867 [TBL] [Abstract][Full Text] [Related]
27. Subtypes of alpha 1-adrenoceptors in hippocampus of pigs, guinea-pigs, calves and humans: regional differences. Hoyer D; Jones CR; Ford W; Palacios JM Eur J Pharmacol; 1990 Jan; 188(1):9-16. PubMed ID: 1968395 [TBL] [Abstract][Full Text] [Related]
28. The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Tseng-Crank J; Kost T; Goetz A; Hazum S; Roberson KM; Haizlip J; Godinot N; Robertson CN; Saussy D Br J Pharmacol; 1995 Aug; 115(8):1475-85. PubMed ID: 8564208 [TBL] [Abstract][Full Text] [Related]
29. Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue. Nasu K; Moriyama N; Kawabe K; Tsujimoto G; Murai M; Tanaka T; Yano J Br J Pharmacol; 1996 Nov; 119(5):797-803. PubMed ID: 8922723 [TBL] [Abstract][Full Text] [Related]
30. Safety profile of selective alpha-1 adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Sciarra A; Di Silverio F Minerva Urol Nefrol; 1997 Mar; 49(1):21-8. PubMed ID: 9099057 [TBL] [Abstract][Full Text] [Related]
31. Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Shibata K; Hirasawa A; Moriyama N; Kawabe K; Ogawa S; Tsujimoto G Br J Pharmacol; 1996 Jul; 118(6):1403-8. PubMed ID: 8832064 [TBL] [Abstract][Full Text] [Related]
32. Distribution of alpha1L-adrenoceptors in canine prostate: characterization by quantitative autoradiography. Suzuki Y; Moriyama N; Okaya Y; Kanada A; Nishimatsu H; Kawabe K; Aisaka K J Pharm Pharmacol; 2000 Jun; 52(6):653-7. PubMed ID: 10875541 [TBL] [Abstract][Full Text] [Related]
33. Autoradiographic localization of alpha 1-adrenoceptors in human prostate: special reference to zonal difference. Kobayashi S; Demura T; Nonomura K; Koyanagi T J Urol; 1991 Sep; 146(3):887-90. PubMed ID: 1652034 [TBL] [Abstract][Full Text] [Related]
35. Detection of alpha 1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization. Moriyama N; Kurimoto S; Horie S; Nasu K; Tanaka T; Yano K; Hirano H; Tsujimoto G; Kawabe K Histochem J; 1996 Apr; 28(4):283-8. PubMed ID: 8762060 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia. Chung JW; Choi SH; Kim BS; Kim TH; Yoo ES; Kim CI; Lee KS; Kwon TG Korean J Urol; 2011 Jul; 52(7):479-84. PubMed ID: 21860769 [TBL] [Abstract][Full Text] [Related]
37. Caveolae contribute to the apoptosis resistance induced by the alpha(1A)-adrenoceptor in androgen-independent prostate cancer cells. Katsogiannou M; El Boustany C; Gackiere F; Delcourt P; Athias A; Mariot P; Dewailly E; Jouy N; Lamaze C; Bidaux G; Mauroy B; Prevarskaya N; Slomianny C PLoS One; 2009 Sep; 4(9):e7068. PubMed ID: 19763272 [TBL] [Abstract][Full Text] [Related]
38. Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine. Kojima Y; Sasaki S; Hayashi Y; Tsujimoto G; Kohri K Nat Clin Pract Urol; 2009 Jan; 6(1):44-53. PubMed ID: 19132005 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study. Park CH; Chang HS; Oh BR; Kim HJ; Sul CK; Chung SK; Jung SI Clin Drug Investig; 2004; 24(1):41-7. PubMed ID: 17516689 [TBL] [Abstract][Full Text] [Related]